<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00510991</url>
  </required_header>
  <id_info>
    <org_study_id>0002</org_study_id>
    <nct_id>NCT00510991</nct_id>
  </id_info>
  <brief_title>Non Invasive Ventilation in Acute Asthma</brief_title>
  <official_title>Non Invasive Ventilation in Acute Asthma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Postgraduate Institute of Medical Education and Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Postgraduate Institute of Medical Education and Research</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the efficacy of noninvasive positive pressure ventilation&#xD;
      versus best medical therapy in patients with acute severe asthma&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the past, the mainstay of treatment for patients progressing to respiratory failure from&#xD;
      acute asthma was intubation and mechanical ventilation. Newer strategies to prevent these&#xD;
      intubations to prevent the inherent complications are being explored in form of various&#xD;
      pharmacological means like heliox, magnesium sulfate etc. Non pharmacological strategies&#xD;
      among which non invasive positive pressure ventilation (NIPPV) is one of the most challenging&#xD;
      after showing success in patients with chronic obstructive airway disease (COPD) and&#xD;
      cardiogenic pulmonary edema.&#xD;
&#xD;
      Data on efficacy of NIPPV in the management of AA is sparse but has the potential to improve&#xD;
      the management of acute severe asthma. Noninvasive ventilation merits further studies in&#xD;
      patients with AA, and some consensus panels have suggested that its widespread application in&#xD;
      patients with asthma await such trials.The role of NIPPV is not yet clear and needs further&#xD;
      studies and keeping this in view we planned this study to study the role of NIPPV in the&#xD;
      management of acute asthma.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2006</start_date>
  <completion_date type="Anticipated">February 2008</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in lung function defined as an increase of at least 50% in FEV1 as compared to baseline value on admission or an increase in FEV1 to &gt; 60% of predicted value</measure>
    <time_frame>Time to discharge</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>Time to discharge</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>Time to discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in the clinical status</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disappearance of pulsus paradoxus</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in arterial blood gases</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in oxygen saturation</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirements of FiO2 , medications.</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for mechanical ventilation</measure>
    <time_frame>Time to discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NIPPV</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nippv</intervention_name>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. History of asthma of at least 1 year&#xD;
&#xD;
          2. FEV1 &lt; 50% of predicted (by age, height, and gender) or FEV1 &lt; 200 L/minute&#xD;
&#xD;
          3. Respiratory rate &gt; 30 breaths/min&#xD;
&#xD;
          4. All patients judged by the attending physician as having an acute attack of asthma (&#xD;
             Inability to speak in sentences in one breath, SaO2 &lt; 92% ,pulsus paradoxus &gt; 10 mm of&#xD;
             Hg) -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Smoking history of &gt; 10 years&#xD;
&#xD;
          2. Chronic obstructive pulmonary disease&#xD;
&#xD;
          3. Endotracheal intubation&#xD;
&#xD;
          4. Room air saturation &lt; 88 % or arterial PaO2 &lt; 55 mm of Hg&#xD;
&#xD;
          5. Hemodynamic instability defined as systolic BP &lt; 90 mm Hg&#xD;
&#xD;
          6. Altered state of consciousness&#xD;
&#xD;
          7. Congestive heart failure&#xD;
&#xD;
          8. Ischemic heart disease&#xD;
&#xD;
          9. Upper airway obstruction&#xD;
&#xD;
         10. Facial deformity&#xD;
&#xD;
         11. Pregnancy&#xD;
&#xD;
         12. Pulmonary infiltrates consistent with pulmonary edema or pneumonia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alok Nath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PGIMER, Chandigarh, India</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Digamber Behera, MD</last_name>
    <phone>00911722756822</phone>
    <email>dbehera@indiachest.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ritesh Agarwal, MD, DM</last_name>
    <phone>0091722756825</phone>
    <email>riteshpgi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PGIMER</name>
      <address>
        <city>Chandigarh</city>
        <zip>160012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Digamber Behera, MD</last_name>
      <phone>00911722756822</phone>
      <email>dbehera@indiachest.org</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>February 2008</verification_date>
  <study_first_submitted>August 2, 2007</study_first_submitted>
  <study_first_submitted_qc>August 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2007</study_first_posted>
  <last_update_submitted>February 26, 2008</last_update_submitted>
  <last_update_submitted_qc>February 26, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2008</last_update_posted>
  <keyword>ASTHMA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>December 2, 2008</submitted>
    <returned>December 30, 2008</returned>
    <submitted>January 8, 2009</submitted>
    <returned>January 15, 2009</returned>
    <submitted>March 22, 2011</submitted>
    <returned>April 13, 2011</returned>
    <submitted>April 15, 2011</submitted>
    <returned>May 8, 2011</returned>
    <submitted>May 25, 2011</submitted>
    <returned>June 22, 2011</returned>
    <submitted>June 12, 2012</submitted>
    <returned>July 13, 2012</returned>
    <submitted>May 13, 2013</submitted>
    <returned>June 18, 2013</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

